Видео ютуба по тегу Aav Cdmo

CDMO Perspective: AAV Manufacturing Challenges & the Role of AI
CDMO Perspective: AAV Manufacturing Challenges & the Role of AI
AAV Outsourcing: Identifying A “High-Quality” CDMO Partner
AAV Outsourcing: Identifying A “High-Quality” CDMO Partner
Webinar - Scalable AAV Manufacturing Strategies
Webinar - Scalable AAV Manufacturing Strategies
The AAV Journey Panel Discussion: Gene Therapy IND Application to Commercialization
The AAV Journey Panel Discussion: Gene Therapy IND Application to Commercialization
Viral Vector track record - Biovian CDMO
Viral Vector track record - Biovian CDMO
Biovian is your CDMO partner in taking biopharmaceuticals to the next level
Biovian is your CDMO partner in taking biopharmaceuticals to the next level
AAV Gene Therapy: From Discovery to Commercialization | CGT Summit 2023
AAV Gene Therapy: From Discovery to Commercialization | CGT Summit 2023
Webinar: PackGene’s Next Generation Dual Plasmid System for AAV Manufacturing
Webinar: PackGene’s Next Generation Dual Plasmid System for AAV Manufacturing
Ana Carreras Gonzalez: Using Maurice for AAV Characterization
Ana Carreras Gonzalez: Using Maurice for AAV Characterization
Designing AAV Gene Therapy: Early Discovery to IND Filing | CGT Summit 2023
Designing AAV Gene Therapy: Early Discovery to IND Filing | CGT Summit 2023
Capacity is Not Enough: Smart Growth as a CDMO
Capacity is Not Enough: Smart Growth as a CDMO
High Throughput Viral Titering of AAV Throughout the Production Continuum
High Throughput Viral Titering of AAV Throughout the Production Continuum
Scalable AAV manufacturing: addressing challenges across the workflow
Scalable AAV manufacturing: addressing challenges across the workflow
Clinical challenges in developing AAV-based gene therapies
Clinical challenges in developing AAV-based gene therapies
Webinar: Advancing AAV Vector Production with High Integrity DNA Constructs - 19.11.2025
Webinar: Advancing AAV Vector Production with High Integrity DNA Constructs - 19.11.2025
The past, present and future of AAV vectors
The past, present and future of AAV vectors
Reasons why clients choose Biovian as a CDMO for viral vector projects – Biovian
Reasons why clients choose Biovian as a CDMO for viral vector projects – Biovian
Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers
Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers
From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment Step
From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment Step
Advanced AAV Processing and Potency through Characterisation of Capsid and Payload Heterogeneity
Advanced AAV Processing and Potency through Characterisation of Capsid and Payload Heterogeneity